1
|
Zhang P, Tu Q, Ni Z, Zheng Z, Chen Y, Yan L, Bao H, Zhuge Q, Ni H. Association between serum calcium level and hemorrhagic progression in patients with traumatic intraparenchymal hemorrhage: Investigating the mediation and interaction effects of coagulopathy. J Neurotrauma 2022; 39:508-519. [PMID: 35102758 DOI: 10.1089/neu.2021.0388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
In this study, we investigate the association of serum calcium with coagulopathy and hemorrhagic progression contusion (HPC) in patients with traumatic intraparenchymal hemorrhage (tIPH), and further explored the interaction and mediation effect between serum calcium as well as coagulopathy on HPC. Retrospective analyses of patients with tIPH admitted to the First Affiliated Hospital of Wenzhou Medical University between January 2016 to December 2019. The clinical data, coagulation parameters, and serum calcium levels were collected for further analysis. Multivariate logistic regression analysis was applied to identify the association of serum calcium level with coagulopathy and HPC. Causal mediation analysis (CMA) and additive interaction model were used to estimate the interaction and mediation effect between serum calcium as well as coagulopathy on HPC. Additionally, we repeated the analysis using corrected calcium. A total of 473 patients were included in this study. Of these, 54 (11.4%) patients had hypocalcemia at admission, 105 (22.2%) presented with coagulopathy, and 187 (39.5%) experienced HPC. Admission serum calcium level in patients presented with coagulopathy and HPC were 8.84 [IQR: 8.44-9.40] and 8.92 [IQR: 8.48-9.40] mg/dL respectively, which were significantly lower than that of patients without (9.10 [IQR: 8.68-9.88] and 9.12 [IQR: 8.72-9.89] mg/dL; all p < 0.001). Multivariate logistic regression analysis identified that hypocalcemia emerged as an independent risk factor for coagulopathy and HPC. However, no significant interaction was detected between hypocalcemia and coagulopathy. CMA showed that the mediator coagulopathy explained 24.4% (95% CI: 4.7-65.0%; p = 0.006) of the association between hypocalcemia and HPC. Moreover, comparable results were held using corrected calcium as well. Admission serum calcium level is associated with the HPC for patients with tIPH and this relationship is partially mediated by coagulopathy, but no significant interaction is detected. Further studies are needed to validate the findings and explore its mechanisms.
Collapse
Affiliation(s)
- Peng Zhang
- The First Affiliated Hospital of Wenzhou Medical University, 89657, Department of Neurosurgery, Wenzhou, Zhejiang, China.,Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, Wenzhou, China;
| | - Qi Tu
- The First Affiliated Hospital of Wenzhou Medical University, 89657, Department of Neurosurgery, Wenzhou, Zhejiang, China.,Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, Wenzhou, China;
| | - Zhihui Ni
- The First Affiliated Hospital of Wenzhou Medical University, 89657, Department of Neurosurgery, Wenzhou, Zhejiang, China.,Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, Wenzhou, China;
| | - Zezheng Zheng
- The First Affiliated Hospital of Wenzhou Medical University, 89657, Department of Neurosurgery, Wenzhou, Zhejiang, China.,Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, Wenzhou, China;
| | - Yu Chen
- The First Affiliated Hospital of Wenzhou Medical University, 89657, Department of Neurosurgery, Wenzhou, Zhejiang, China.,Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, Wenzhou, China;
| | - Lin Yan
- The First Affiliated Hospital of Wenzhou Medical University, 89657, Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, Wenzhou, Zhejiang, China.,The First Affiliated Hospital of Wenzhou Medical University, 89657, Department of Neurosurgery, Wenzhou, Zhejiang, China;
| | - Han Bao
- The First Affiliated Hospital of Wenzhou Medical University, 89657, Department of Neurosurgery, Wenzhou, Zhejiang, China.,Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, Wenzhou, China;
| | - Qichuan Zhuge
- The First Affiliated Hospital of Wenzhou Medical University, 89657, Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, Wenzhou, Zhejiang, China.,The First Affiliated Hospital of Wenzhou Medical University, 89657, Department of Neurosurgery, Wenzhou, Zhejiang, China;
| | - Haoqi Ni
- The First Affiliated Hospital of Wenzhou Medical University, 89657, Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, wenzhou, Wenzhou, Zhejiang, China, 325000.,The First Affiliated Hospital of Wenzhou Medical University, 89657, Department of Neurosurgery, wenzhou, Wenzhou, Zhejiang, China, 325000;
| |
Collapse
|
2
|
The effects of antithrombotic therapy on head trauma and its management. Sci Rep 2021; 11:20459. [PMID: 34650114 PMCID: PMC8516855 DOI: 10.1038/s41598-021-00091-2] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2021] [Accepted: 10/07/2021] [Indexed: 11/16/2022] Open
Abstract
The number of patients with traumatic intracranial hemorrhage (tICH) that are taking antithrombotics (ATs), antiplatelets (APs) and/or anticoagulants (ACs), has increased, but the influence of it for outcome remains unclear. This study aimed to evaluate an influence of AT for tICH. We retrospectively reviewed all patients with tICH treated between 2012 and 2019, and analyzed demographics, neurological status, clinical course, radiological findings, and outcome data. A total of 393 patients with tICH were included; 117 were on AT therapy (group A) and 276 were not (group B). Fifty-one (43.6%) and 159 (57.6%) patients in groups A and B, respectively, exhibited mRS of 0–2 at discharge (p = 0.0113). Mortality at 30 days was significantly higher in group A than in group B (25.6% vs 16.3%, p = 0.0356). Multivariate analysis revealed that higher age (OR 32.7, p < 0.0001), female gender (OR 0.56, p = 0.0285), pre-injury vitamin K antagonist (VKA; OR 0.42, p = 0.0297), and hematoma enlargement (OR 0.27, p < 0.0001) were associated with unfavorable outcome. AP and direct oral anticoagulant were not. Hematoma enlargement was significantly higher in AC-users than in non-users. Pre-injury VKA was at high risk of poor prognosis for patients with tICH. To improve outcomes, the management of VKA seems to be important.
Collapse
|